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Edited by Y. ShiAbstractAnterior gradient 2 (AGR2) is a normal endoplasmic reticulum protein that has two important abnormal
functions, amphibian limb regeneration and human cancer metastasis promotion. These normal intracellular
and abnormal extracellular roles can be attributed to the multidomain structure of AGR2. The NMR structure
shows that AGR2 consists of an unstructured N-terminal region followed by a thioredoxin fold. The protein
exists in monomer–dimer equilibrium with a Kd of 8.83 μM, and intermolecular salt bridges involving E60 and
K64 within the folded domain serve to stabilize the dimer. The unstructured region is primarily responsible for
the ability of AGR2 to promote cell adhesion, while dimerization is less important for this activity. The structural
data of AGR2 show a separation between potential catalytic redox activity and adhesion function within the
context of metastasis and development.
© 2012 Published by Elsevier Ltd. Open access under CC BY license. Introduction
Anterior gradient 2 (AGR2) is a major develop-
ment-regulating protein that specifies the formation
of embryonic ectoderm of tadpoles1 and induces
the remarkable effect of limb regeneration in
salamanders.2 In mammals, AGR2 is produced in
a restricted number of normal tissues, most notably
in the secretory goblet cells of the intestine,3 where it
is associated with normal processes of secretion of
mucin,4 a large cysteine-rich glycoprotein that pro-
tects the inner lining of the intestine.
AGR2's rise to prominence among proteins that
control development, however, has been its role in
abnormal progression of disseminated disease, in
particular, cancer. In oncogenesis, AGR2 is upregu-
lated in theprimary tumorsof breast,5,6 lung,7 ovarian,8
oesophageal,9 pancreatic10 and prostate cancers.11
Its elevated level in breast and prostate cancer is asso-
ciated with markedly reduced survival of patients.11–140022-2836 © 2012 Published by Elsevier Ltd. Open access under CC BAGR2 has been found in circulating tumor cells
from breast, colon and prostate cancer patients,15
in the circulating blood of patients with ovarian
cancer16 and in ectopic lesions of the non-malignant
condition of endometriosis,17 hence suggesting a
potential role for AGR2 in cancer dissemination.
Overexpression of AGR2 in a benign mammary cell
system induced a metastatic dissemination to other
organs, particularly the lungs, when transplanted
into the mammary glands of syngeneic rats.6 In
this metastatic model, a change in cell activity
induced by AGR2 was an enhanced rate of
cell adhesion.6
AGR2 is distantly related to the large protein
disulfide isomerase (PDI) family. Its primary se-
quence contains a signal sequence between resi-
dues 1 and 20, which is required for import into the
endoplasmic reticulum but is not found in the mature
protein. AGR2 also contains an atypical C-terminal
endoplasmic reticulum retention sequence, KTEL.18J. Mol. Biol. (2013) 425, 929–943Y license. 
930 Structure and Activity of AGR2AGR2 has a single CXXS motif that is likely to be
responsible for its normal role by forming mixed
disulfides with the intestinal mucin MUC24, mucins
MUC119 and MUC5AC.20 A closely related protein,
AGR3,21 of unknown function also contains a 21-
amino-acid signal sequence for endoplasmic retic-
ulum entry and is about 72% identical with amino
acids 41–175 of AGR2. However, at the N-
terminus, outside the signal peptide region, AGR3
has a shorter segment corresponding to AGR2
amino acids 21-40 (Fig. 1).
We describe here the first structure of AGR2
(without the 20-amino-acid signal peptide) and show
that the N-terminal amino acid region 21–40 is
unfolded and that the C-terminal domain adopts the
thioredoxin fold. The N-terminal region is primarily
responsible for the cell adhesion properties of
AGR2, whereas the folded domain forms a dimer
through specific intermolecular salt bridges. AGR2,
therefore, appears to have a bifunctional role in
promoting cell adhesion and in PDI-like reactions.
Results
Biophysical characterization of AGR2
AGR221–175 and the truncated AGR241–175 (Fig. 1)
have a molecular mass of 30.6±0.1 kDa and 26.0±
0.1 kDa, respectively, rather than the correspondingFig. 1. Sequence of AGR2 and AGR3. Sequence alignment
sequences are shown without their N-terminal signal peptides
indicate the residues that were mutated during these studies.
paper are shown above the sequence.theoretical molecular mass of 17.8 kDa and
16.1 kDa, suggesting that both proteins exist in
equilibrium betweenmonomers and dimers (Fig. 2a).
The determined molecular mass suggests that the
region 21–40 makes only minimal, if any, contribu-
tion to the dimerization.
The heterogeneous nature of AGR2 is not unique;
the closely related protein AGR3, which shares 65%
amino acid sequence identity with AGR2, is a
mixture of species with a molecular mass ranging
from 31.5 kDa to 26.3 kDa (Fig. 2a). Mutation of the
only cysteine residue in AGR241–175, C81 to serine,
had a minimal effect on its dimeric state (Fig. 2b) and
treatment with DTNB [5,5′-dithiobis-(2-nitrobenzoic
acid)] showed that this cysteine residue exists in the
reduced state, thereby eliminating an intersubunit
disulfide bridge. The monomer–dimer equilibrium of
AGR241–175 was investigated using equilibrium
analytical ultracentrifugation (Fig. 2d). The results
fit well to a monomer–dimer distribution model, with a
random distribution of residuals. The association
constant (log10 Ka) was 5.054, indicating that the
concentration for dissociation is approximately
8.83 μM. Therefore, at the 0.5- to 1-mM concentra-
tions used for the structural studies, the protein is
predominantly a dimer.
The 1H–15N heteronuclear single quantum co-
herence (HSQC) spectrum of AGR221–175 contains
a mixture of well-dispersed and intense poorly
dispersed resonances, whereas the AGR241–175of AGR221–175, AGR324–166, Erp18 and thioredoxin A. The
. Conserved residues are shaded in red. The asterisks (*)
Secondary structure elements of AGR2 determined in this
l 
Fig. 2. MALLS and analytical ultracentrifugation characterization of AGR2 and AGR3. (a) MALLS analysis of wild-type
AGR2 21–175, AGR241–175 and AGR324–166. The major isolated peak for AGR241–175 has a mean molecular mass of 26.0±
0.1 kDa, 31.1±0.6 kDa for AGR221–175 and 30.6±0.1 kDa for AGR324–166, rather than the expected molecular mass of,
respectively, 16.1 kDa, 17.8 kDa and 16.9 kDa (for monomers) or 32.2 kDa, 35.6 kDa and 33.8 kDa (for dimers),
confirming monomer–dimer equilibrium. (b) MALLS analyses of AGR241–175 and its mutants E60A, C81S, Y63A and K64A
confirm that mutation of the E60 residue abolishes dimerization whereas mutation Y63 or K64A disrupts, rather than
abolishes, dimerization. The minimal effects of the C81S mutation indicate that dimerization is not due to intersubunit
disulfide linkages. (c) MALLS analysis of AGR221–175 and E60A AGR221–175 confirms that residue E60 plays an important
part in AGR2 dimerization. (d) Fitting of AGR241–175 equilibrium analytical ultracentrifuge data to a monomer–dimer
equilibrium at 62 μM, 31 μMand 6 μM. The sample was in 20 mM sodium phosphate (pH 6.5) with 150 mMNaCl at 20 °C.
The results fit well to a monomer–dimer distribution model with a random distribution of residuals to give a dissociation
constant of 8.83 μM under these conditions.
931Structure and Activity of AGR2spectrum consists of predominantly well-dispersed
cross-peaks. This suggests that the first 20 amino
acids of AGR221–175 are largely unstructured. The
absence of peak doubling in the 1H–15N HSQC
spectrum of AGR241–175 indicates that the dimer is
symmetrical (Fig. 3a). The monomer–dimer equilib-
rium significantly reduced the NMR spectral quality
through chemical exchange line-broadening and
made the resonance assignments and structure
determination more challenging. However, since
there were no suitable proteins against which
modeling could be undertaken to identify the
residues responsible for dimerization, it was not
possible to convert the dimeric state to a monomer
through mutagenesis until after the structure of the
dimer was determined. Besides, there were also no
previous data that identified the specific roles, if any,
of the structured and unstructured domains of
AGR2. Hence, NMR studies were pursued withconditions under which the protein was predomi-
nantly dimeric.
NMR studies of AGR241–175 homodimer
To obtain good quality data, a combination of high-
level deuterium labeling of the protein, selective 13C-
methyl labeling and transverse relaxation optimized
spectroscopy-based NMR experiments was re-
quired to yield complete backbone resonances
(15N, 1H, 13Cα, 13Cβ and 13C′) and the important
nuclear Overhauser enhancement (NOE) data re-
quired for structure determination. Leucines, iso-
leucines and valines account for nearly 24% of the
AGR241–175 polypeptide sequence, and these side-
chain resonances were readily assigned using the
three-dimensional (3D) (H)CCH3–TOCSY experi-
ments (Fig. 3b) 22 on {[U- 15N, 13C, 2H], Ile δ1
[13CH3],Leu,Val[
13CH3]}AGR241–175. The residue-
Fig. 3. Spectra of AGR241–175.
(a) 15N–1H HSQC spectrum of
{[U-15N,13C,2H]}AGR241–175. (b)
Strips from the 3D (H)CCH3–
TOCSY expe r imen t s us i ng
{[U-15N,13C,2H], Ileδ1[13CH3],Leu,
Val[13CH3]}AGR241–175 showing
the side-chain assignments of
Val110, Val125 and Ile128. (c) The
assigned methyl region of the
1H– 13C HSQC spect rum of
{[U-15N,13C,2H], Ileδ1[13CH3],Leu,
Val[13CH3]}AGR241–175. Asterisks
(*) represent peaks with multiple or
ambiguous assignments.
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933Structure and Activity of AGR2specific assignments (Fig. 3c) enabled the NOE
spectroscopy (NOESY) spectrum to be assigned
and the generation of the key distance restraints.
The monomer subunit structure was calculated
using 595 inter-proton distance restraints obtained
from methyl-methyl, methyl-HN and HN-HN NOE's;
95 residual dipolar coupling (RDC) restraints mea-
sured in two different alignment media [Pf1 bacteri-
ophage and 5% (v/v) pentaethylene glycol
monododecyl ether:hexanol in a 0.96:1 ratio]; 179
TALOS-derived backbone torsion angles and 37
hydrogen bonds. The 10 calculated structures with
the lowest total free energy and the least number of
violations have a backbone RMSD of 0.42 Å for the
structured regions (Table 1 and Fig. 4a). It is
interesting to note that, despite the low number of
NOE restraints, it is possible to obtain a high-
resolution structure. This is due to the fact that the
distance restraints that are important to “fold” the
protein are available, since they often involve amino
acid residues with methyl groups.
Dimerization of AGR241–175 occurs via the
antiparallel arrangement of the α1 helix
Although it was possible to produce heterodimers
composed of unlabeled and 13C/15N AGR241–175
(Fig. S1), no intermolecular NOEs were detected
using the inherently insensitive 13C/15N-filtered NOE
experiments. We, therefore, used an RDC-assistedTable 1. Structure statistics for AGR241–175 and E60A
AGR241–175
AGR241–175 E60A AGR241–175
NMR distance and dihedral constraints
Distance constraints
Total NOE 595 2364
Ambiguous 22 253
Intra-residue 73 993
Inter-residue 500 1118
Sequential (|i− j|=1) 218 572
Medium range (|i− j|b4) 142 314
Long range (|i− j|N5) 141 232
Hydrogen bonds 37 40
Total dihedral angle restraints
φ 90 82
ψ 89 80
Total RDCs 95 57
NH phage 43 57
NH PEGa 52 —b
RDC Q-factor 0.018 0.101
Average pairwise RMSD** (Å)
Heavyb 1.31 1.55
Backbonec 0.42 0.59
a NH PEG RDCs were not collected.
b RMSD calculated with CNS.
c Ten structures were superimposed using the backbone atoms
of residues in secondary structure elements of AGR241–175 (58–
67, 72–77, 82–93, 95–103, 105–108, 127–132, 135–138 and
157–168). The corresponding secondary structures are α1, β1,
α2, α3, β2, β3, β4 and α4.modeling method, which was reported to be suitable
for the determination of the solution structures of
symmetrical dimers,23 to determine the structure of
the AGR241–175 dimer. In this approach, RDCs are
first used to obtain the orientation of the symmetry
axis relative to the monomer structure. As the
symmetry axis adopts the same orientation relative
to the monomers, irrespective of alignment media,
two non-degenerate alignment tensors should share
a common axis, enabling the orientation of the
symmetry axis to be identified. AGR241–175 dimer
was aligned in Pf1 bacteriophage and 5% (v/v)
pentaethylene glycol monododecyl ether:hexanol in
a 0.96:1 ratio; the RDCs were measured and the
orientation of the symmetry axis was determined as
described in the experimental procedure (Fig. 4c and
d). Homodimer models in agreement with these
symmetry restraints were then constructed using the
grid-search algorithm, and these models were
evaluated based on the quality of the interface
between the subunits and the agreement with the
experimental data.
The correlation between the measured and back-
calculated dimer RDCs shows a good fit between the
two values, with a Q value of 0.018 for data acquired
in both phage and polyethylene glycol (PEG). The
AGR241–175 dimer model structure obtained (Fig. 5a)
shows that the interface is made up of the α1 helix,
with a buried area of approximately 812 Å2. Across
the representative models of the ensemble, the ionic
interaction between E60 of one subunit and K64 of
the other (labeled as K64*) is absolutely conserved
with intact electrostatic interactions between the two
side-chain carboxylate oxygens of E60 and the side-
chain ammonium hydrogen of K64 (Fig. 5b). Both
these residues are located in the α1 helix, and hence
the E60–K64* electrostatic interaction can only be
achieved through an antiparallel arrangement of the
α1 helix (Fig. 5b and c). Y63–Y63* hydrophobic
interactions are also possible from the model.
Further evidence that the α1 helix forms the dimer
interface was obtained from amide solvent protec-
tion data obtained using paramagnetic relaxation
agents (Fig. 5a and Fig. S2).
Mutagenesis of residues responsible
for dimerization
The importance of E60, Y63 and K64 in forming
the intermolecular interactions was tested by mutat-
ing each to an alanine followed by characterization
using multi-angle laser light scattering (MALLS)
(Fig. 2b). E60A AGR241–175 is a monomer (molec-
ular mass, 16.4 kDa). The K64A (molecular mass,
18.7 kDa) mutant exhibits disrupted dimerization,
thus confirming the importance of the E60–K64
interaction in maintaining the dimer structure. The
molecular mass of Y63A AGR241–175 (molecular
mass, 18.9 kDa) is similar to that of the K64A
Fig. 4. Overall structure of AGR2
monomer subunit and directions of
alignment axis for of AGR241–175.
(a) Superposition of the 10 lowest-
energy conformers of monomer
subunit of AGR241–175. (b) Ribbon
representation of the subunit struc-
ture of AGR241–175 with the sec-
ondary structures marked. (c)
Sauson-Flamsteed plot showing
orientations of the principle align-
ment tensor solutions calculated
from RDCs of AGR241–175 in Pf1
bacteriophage and 5% pentaethy-
lene glycol monododecyl ether:hex-
anol in a 0.96:1 ratio. The overlap of
the PEG Sxx and bacteriophage
Syy alignment tensor axes indi-
cates the C2 symmetry axis of
AGR241–175. (d) The order tensor
directions plotted onto the molecu-
lar frame of AGR241–175 to show the
symmetry axis obtained from the
two alignment media.
934 Structure and Activity of AGR2mutant. The MALLS analysis of AGR221–175 and
E60A AGR221–175 further shows that AGR2 dimer-
ization occurs independently of residues 21–40
(Fig. 2c), since both proteins dimerize irrespective
of whether or not these N-terminal residues are
present. The intersubunit E60–K64* salt bridge is
confirmed by the effects of salt concentration on the
stability of the dimer. A comparison of the chemical
shifts between the monomeric E60A AGR241–175
and the wild-type AGR241–175 protein shows that the
residues whose chemical shifts are most affected
are from the α1 helix (Fig. S3).Structure determination of the E60A
AGR241–175 monomer
E60A AGR241–175 is monomeric in solution. The
structure of E60A AGR241–175, determined using
standard methods, yielded 10 low-energy and least
restraint violation structures (Table 1 and Fig. 6a
and b). The all-atom RMSD between the mutant
and one subunit of the wild-type dimer is 2.82 Å
(Fig. 6c), confirming the structure of the latter, which
was obtained using a significantly reduced number
of structural restraints. E60A AGR241–175 had a
Fig. 5. Structural analysis of
AGR241–175 homodimer. (a) Homo-
dimeric model of AGR241–175 show-
ing the antiparallel arrangement of
the α1 helix. (b) Dimeric interface,
with the residues comprising the α1
helix represented as sticks. The
intersubunit salt bridge between
the carboxylate group of Glu60
and the ammonium group of Lys64
forms the major interaction between
the subunits, with the Y63–Y63
hydrophobic interaction having
some influence on dimer stability.
(c) Complementary charged sur-
faces at the dimer interface with
surface representation for one and
ribbons for the other subunit. (d)
Ribbon representation of AGR241–175
mapped according to paramagnetic
relaxation effect induced by the
presence of Gd(III)-DTPA. Re-
gions of high solvent protection are
colored blue and regions of low
solvent protection or no data avail-
able are colored green. Regions are
considered to have high solvent protection if the peak intensity ratio, calculated from 15N HSQC spectra of AGR241–175
collected in the presence and absence of 2 mM Gd(III)-DTPA, is above 0.65 and are considered to have low solvent
protection if the peak intensity ratio is below 0.65.
935Structure and Activity of AGR2tendency to aggregate over time, degrading the
overall quality of the NMR data, especially those
involving residues that form the dimer interface in the
wild-type protein. This explains why the structure of
the monomer is of lower quality than that of the
dimer. The solution-state characteristics of the
monomeric protein suggest that AGR2 requires a
binding partner (either another protein or itself) to
achieve structural stability.
Overall structure of AGR2
Each AGR241–175 monomer subunit consists of a
four-stranded β-sheet core surrounded by four α-
helices: α1 (residues 58–67), β1 (residues 72–77),
α2 (residues 82–93), α3 (residues 95–103), β2
(residues 105–108), β3 (residues 127–132), β4
(residues 135–138) and α4 (residues 157–168)
(Fig. 4b). This α-β-α-α-β-β-β-α arrangement is
similar to a thioredoxin fold. The active-site CPHS
motif is located at the N-terminal end of the α3 helix,
consistent with other known structures of thioredoxin
domains.24 The α3 and α4 helices are bent with
respect to each other at an angle near to 90°. A short
310 helix is present in the region between the β2 and
β3 strands, which is otherwise intrinsically disor-
dered. Another 19-residue region of intrinsic disorder
occurs between the β4 and α4 structural elements;
within this region is an insertion consisting of
residues 150–156, which is unique to AGR2,AGR3 [Protein Data Bank (PDB) accession number
3PH9] and Erp18,25 when compared to other PDI
family functional domains.
The structure of AGR2 possesses features typi-
cally observed in members of the PDI family. The
conserved proline (P126 in AGR2) at the start of β3,
like other PDI family members, is in the cis
conformation (Fig. 6d). This conserved cis proline
is located close to the potential catalytic active site
and has been shown to be important for preserving
the structural integrity of the active site for both
substrate binding and catalysis in other PDI mem-
bers. Another feature of thioredoxin domains, also
found in the AGR241–175 structure, is the broken helix
immediately following the CXXC(S) motif. However,
rather than a proline being present in this kink, as
found in many PDI domains, the corresponding
residues in AGR2 are Asn94 and Lys95. In the case
of the closely related AGR3 (GI: 66774045), the
equivalent residues are Asn84/Glu85.
Similar to human PDI, Erp44 and Erp18, a
hydrophobic patch formed by residues including
A86, V90, I92, Y124, V125, I128, Y150, A151, Y152
and L161 can be found surrounding the CPHS motif
(Fig. 6e) of AGR2. As has been shown or postulated
for other PDI proteins, this large hydrophobic patch
could be involved in binding target proteins.
We have detected neither isomerase nor glutar-
edoxin activity using biochemical enzymatic assays
and standard substrates, although mixed disulfide
Fig. 6. Structure of E60A AGR241–175. (a) Superposition of the 10 lowest-energy conformers of monomer subunit of
E60A AGR241–175. Structures were calculated with a total of 2257 NOE-derived distance restraints, 162 dihedral angles,
40 hydrogen bonds and 57 RDC restraints. (b) Ribbon representation of the structure of E60A AGR241–175 with the
secondary structures indicated. (c) Superposition of lowest-energy conformers of AGR241–175 and E60A AGR2 with an all-
atom RMSD of 2.82 Å between the two structures. (d) Catalytic active-site conformation in PDIs. This is well formed
around the CXXC motif of Erp18 (PDB ID: 1SEN) (left) in comparison with the poorer conformation of CPHS in AGR2
(right). The cis proline is a structural requirement for correct function in PDI members. (e) Hydrophobic patch (brown)
around the CPHSmotif (green) shows its location is distant from the dimerization helix α1 (red). The orientations of the two
structures differ by 180°.
936 Structure and Activity of AGR2formation between AGR2 and MUC2 has been
reported.4 In PDIs, there has been considerable
attention paid to the buried glutamate and lysine salt
bridge within the proximity of the cysteines in the
CXXC motif; in human PDI (GI: 110815912), these
are formed between Glu49 and Lys83. In AGR2, the
corresponding residues, I75 and N108, do not form
salt bridges, similar to the structure of Erp44 where
the equivalent residues are Asn23 and Arg60.26 In
addition, the highly conserved Arg120 in human PDI
has been shown, through mutation analysis, to have
a direct effect on catalytic activity. This residue
occurs in an unstructured region of the protein, with
its side chain able to adopt a continuum of
conformations ranging from totally solvent exposed
to buried conformations, in which it is able to form
other hydrogen bonding networks. The movement of
the Arg side chain, in and out of the active site,
affects the pKas of both active-site cysteines, and
this modulation is important in the thiol-disulfide
catalytic cycle. In AGR2, this conserved arginine
(Arg128) also adopts a range of conformations27
and is likewise expected to play a role in modulating
the pKa of the active-site cysteine during this cycle.Amino acids 21–40, not dimerization, determine
the effect of AGR2 on the rate of cell adhesion
AGR221–175, when coated on plastic substrata,
significantly enhances the rate of adhesion of rat
mammary tumor cells6 by 2.4-fold over uncoated
substrata (adhesion efficiencies, 45.0±1.4% and
18.6±1.3%, respectively; Pb0.001, Student's t test)
(Fig. 7). In contrast, AGR241–175, which lacks the 21–
40 region, not only failed to enhance the rate of cell
adhesion but also, like the negative control protein
bovine serum albumin, exhibited a significantly
reduced rate relative to uncoated wells (adhesion
efficiencies: AGR241–175, 10.4±0.2%; bovine serum
albumin, 3.6±1.5%; P=0.001 and Pb0.001, respec-
tively, compared to uncoated plates, Student's t test)
(Fig. 7). The importance of amino acids 21–40 of
AGR2 in enhancing the rate of cell adhesion was
further demonstrated by the closely related protein
AGR324–166, in which segment 21–40 of AGR2 is
replaced by 9 amino acids in AGR3, of which 7 are
identical with or similar to those found in AGR2.
However, unlike AGR221–175, AGR324–166 exhibited
similar adhesion ability (adhesion efficiency, 12.9±
Fig. 7. AGR2 residues 21–40 are necessary for
promoting cell adhesion. 24-well tissue culture plates
with the indicated proteins or with coating buffer only
(uncoated). Following a 60-min incubation with Rama 37
cells, adhering cells were counted and adhesion efficien-
cies were calculated as the percentage of starting cells that
adhered to the plate. Each condition was carried out in
duplicate and the data represent the mean±standard error
of the duplicates from six independent experiments for
uncoated and AGR221–175 or three independent experi-
ments for other conditions. The adhesion efficiencies of
dimer AGR221–175 and monomer E60 AGR221–175 are
similar, showing that dimerization is not important for the
adhesion properties of AGR2. The effect of removal of the
N-terminal region, 21–40, shows the importance of this
region for adhesion.
937Structure and Activity of AGR22.4%; P=0.43, Student's t test) to the truncated
AGR241–175 (Fig. 7). This suggests that the role in
cell adhesion is specific for the N-terminal sequence
21–40 of AGR2. However, further investigation
showed that a synthetic peptide consisting of this
polybasic amino acid sequence 21–40 of AGR2
alone was unable to promote an enhanced rate of
adhesion of the cells to the substratum (Fig. S4). It
would appear that the folded domain must also be
present and covalently linked to the 21–40 peptides
to increase the rate of cell adhesion. However, an
SXXS mutant of AGR221–175, which might be
expected to abolish any potential PDI or disulfide-
forming activity by AGR2, exhibited the same
enhancement of adhesion as the non-mutant
protein (Fig. S5), suggesting that these activities
are not associated with the adhesion-enhancing
activity of AGR2.
The monomeric mutant proteins E60A AGR221–175
and E60A AGR241–175 exhibited rates of cell adhe-
sion (48.3±4.3% and 11.5±0.3%, respectively) that
were not significantly different from the corresponding
native dimeric proteins, AGR221–175 and AGR241–175
(P=0.58 and P=0.74, respectively, Student's t test)
(Fig. 7). This shows that monomeric and dimeric
forms have similar cell adhesion properties.Discussion
NMR structure of AGR2
The AGR2 dimer and monomer structures
described here are examples, which clearly
demonstrate that the quality rather than the
number of NOEs is important for obtaining a
high-resolution structure, provided that NOEs are
supplemented with RDC restraints.
The experiments to confirm the dimer structure—
mutagenesis and solvent protection—are neces-
sary, since the method used to obtain this structure
is a modeling approach, assisted by experimental
restraints.23 One of the main problems with this
method is reproducibility, although other factors are
also important. The method relies on two assump-
tions. The first one is that the multimer in question
possesses C2 symmetry around the symmetry axis;
for the vast majority of biological homodimers, this is
a safe assumption. The second assumption is that
the calculated starting subunit structure is good
enough to produce an accurate representation of the
oligomeric complex. The initial AGR2 subunit struc-
ture was calculated with limited NOEs due to the
isotope labeling schemes adopted, which were
necessary to overcome the line-broadening effects
and allow good data for resonance assignments and
to provide the crucial NOEs to determine the protein
fold. An added advantage of the labeling scheme
used is that there is little possibility of misinterpreting
intersubunit NOEs as intrasubunit NOEs, or vice
versa. Furthermore, intersubunit NOEs are unlikely
to be observed in the NOESY spectra because of the
nature of the labels introduced. In theory, these
sparse NOEs could have led to very poor structures;
in the event, however, when supplemented with
high-quality RDCs, good structures of the monomer
subunits are obtained, giving confidence to the final
dimer structure.
Dimerization of AGR2
The RDCs are also crucial for calculating the dimer
structure. The rigid-body docking method is followed
by minimization at the interface, back-calculation of
the RDCs of the homodimer and then analysis of the
quality of the interface. It is, however, not difficult to
imagine situations where flexible or other regions in
a structure could interfere with the docking of the
subunits, resulting in these dimer structures being
rejected as plausible structures. One other condition
that is required for this method to work is that, in
cases where there might be a mixture of species in
equilibrium, the oligomer being calculated is the
dominant contributor to the RDC data being
collected.23 In the case of AGR2, which has been
shown to have a dissociation constant of 8.8 μM, the
938 Structure and Activity of AGR2vast majority of the protein in solution is in a
homodimer form; thus, this condition is satisfied.
Only a limited number of PDIs exist as dimers;
yeast PDI, which contains multiple active and
inactive thioredoxin domains, forms dimers by in-
teractions involving the inactive thioredoxin b′
domain.28 However, this domain is not present in
AGR2. Erp29, which contains a single thioredoxin
fold with a single CLPC active site, forms a tight
dimer with an extensive dimer interface consisting of
multiple electrostatic and hydrophobic interactions
involving residues toward its N-terminal region.29
Erp16/18 also resembles AGR2 and AGR3 in
possessing only one thioredoxin fold; although
originally thought to be a dimer,30 this was not
confirmed in the NMR structure, which showed
Erp16/18 to be a monomer.25 That Erp16/18 is a
monomer is not surprising from our structure of
AGR2; both lysine and tyrosine residues corre-
sponding to positions 64 and 63, respectively, in
AGR2, that are identified in the present paper to
have a role in AGR2 dimerization are absent in
Erp16/18.
A comparison of the amino acid sequences of
AGR2 from 21 species (Fig. S6) shows that amino
acid 63 is conserved as Y in amphibians, marsupials
and mammals and as a highly conservative substi-
tution to F63 in fish and birds. E60 is conserved in all
21 species from zebrafish to humans, and K64 is
conserved in amphibians, marsupials and mam-
mals, but as R in mouse. However, in fish, K64 is
hydrophobic W (or L in one case), suggesting that
fish AGR2 either does not form dimers or does not
form dimers through the same salt bridge, relying
perhaps on the hydrophobic interactions involving F
or Y at position 63. A comparison of the amino acid
sequence of AGR3 from 15 species (Fig. S7) shows
that the glutamic acid, which corresponds to position
60 in AGR2, is conserved in 14 out of 15 species,
including fish, except as D in Northern Pike;
however, the position in AGR3 corresponding to
position K64 of AGR2 is not conserved at all, even in
human AGR3. This result is consistent with the
MALLS experiments on human AGR3, which
showed self-association of AGR3 but, in contrast to
human AGR2, behaved heterogeneously, with mo-
lecular mass varying from 23 kDa to 37 kDa. Thus,
AGR3 behaves differently from AGR2 with regard to
oligomer formation.
A role of AGR2 dimerization has yet to be defined,
in common with some better-characterized mem-
bers of the PDI family.25,28,29 The calculated
dissociation constant of dimerization in the present
paper suggests that AGR2 is dimeric in its normal
location of the endoplasmic reticulum, where high
concentrations will be maintained. Since one normal
client protein of AGR2, the cysteine-rich MUC2,4 is
multimeric, this dimerization may enable AGR2 to
present multiple sites for MUC2 binding. It is notablethat the dimerization interface of AGR2 is located at
the region far from the hydrophobic patch around
the catalytic CPHS motif (Fig. 6e), suggesting that
this patch is free to interact with other client
proteins. Hydrophobic interactions have been
reported to be important for the interaction between
PDI and a large substrate, creatine kinase. Further-
more, at higher concentrations of PDI, the formation
of PDI oligomers was associated with a chaperonin
activity, rather than with protein folding activity.31 A
similar change in function from folding to chaperone
has been reported to be associated with the
concentration-dependent oligomerization of the
Arabidopsis thioredoxin-like protein, AtTDX.32
Thus, the dimerization of AGR2 may also play a
role in its normal function.
Normal and abnormal roles of AGR2
The results here are consistent with AGR2
exhibiting normal intracellular and abnormal extra-
cellular roles. In normal cells, intracellular AGR2
forms mixed disulfides with mucins, MUC1, MUC2
and MUC5AC,4,19,20 and thereby contributes to
their secretion. In tumor cells, however, AGR221–175
can stimulate cell adhesion activity.6 The results
here are also consistent with reports that AGR2 is
not only located on the cell surface in cancer cells
using immunofluorescence techniques33 and se-
creted from pancreatic cancer cells,10 but also
found in the blood and possibly urine of, respec-
tively, ovarian16 and prostate34,35 cancer patients.
AGR2, however, is not unique among PDI-related
proteins by acting extracellularly at the cell mem-
brane. Other proteins that contain thioredoxin folds
have been found to play important roles on the cell
surface because many cell surface proteins contain
disulfide linkages.36,37 PDI and related endoplas-
mic reticulum proteins can influence, through their
catalytic activity on the cell surface, the behavior of
diverse receptors,38 proteases39 and particularly
cell adhesion molecules such as integrins.37 PDI
itself catalyses disulfide exchange on integrins to
enhance platelet adhesion40; blocking cell surface
PDI with function-blocking PDI-specific antibodies
specifically reduces fibrinogen-mediated platelet
aggregation.41 The unstructured region, amino
acids 21–40, of AGR2 is required for the cell-
adhesion-promoting activity of AGR2. Thus, it is
likely that the unstructured region serves to attach
the AGR2 protein to the substratum, allowing the
structured part of the protein to mediate cell
adhesion, either by interacting, in a dimerization-
independent manner, with one of its proposed cell
surface targets, for example, dystroglycan or
C4.4a,5 or alternatively, through a specific thior-
edoxin activity, to interact with the cell surface. The
observation that the SXXS mutation does not
reduce the adhesion-promoting effect of AGR2
939Structure and Activity of AGR2suggests that the adhesion-promoting effect of
AGR2 may be mediated by binding to one of its
partner proteins, further highlighting an abnormal
extracellular role for AGR2.
However, how AGR2 functions at the tumor cell
surface to induce cell adhesion in cancer develop-
ment and metastasis 6 and to affect patient
survival12–14 is largely unknown. The elucidation of
the 3D structure of AGR2 has revealed a separation
between potential catalytic redox activity and
adhesion function within the context of metastasis
and development.Materials and Methods
Plasmids for expression of proteins
Wild-type cDNA encoding human AGR221–175 (residues
21–175) (GI: 68012759) was cloned into the pTWIN1
vector (NEB), and the AGR241–175 construct was gener-
ated by subcloning the relevant part of AGR221–175 cDNA
into pET151-D vector (Invitrogen). The E60A AGR221–175,
E60A AGR241–175, C81S AGR241–175, K64A AGR241–175
and Y63A AGR241–175 mutations were generated using a
QuikChange site-directed mutagenesis kit (Stratagene), in
accordance with the manufacturer's instructions. Details of
the primers are given in Supplementary Data.
Protein expression and purification
Unlabeled AGR221–175 and AGR241–175, including all
mutants, were expressed in LB medium. [U-15N], [U-15N,
13C]AGR241–175 and E60 AGR241–175, [U-
15N,13C,2H]
AGR241–175 and {[U-
15N,12C,2H], Ileδ1[13CH3],Leu,Val
[13CH3]}AGR241–175 were prepared for these studies. For
[U-15N] and [U-15N,13C]proteins, expressions were carried
out inM9mediumcontaining 1 g/L 15NH4Clwith either 4 g/L
12C-glucose or 13C-glucose. For the production of [U-15N,
13C,2H]AGR241–175, Silantes OD2 medium was used
(Silantes GmbH). The bacteria were grown to an OD600 of
0.5–0.6 at 37 °C, and protein expression was induced with
1 mM IPTG overnight at 18 °C.
Wild-type {[U-15N,13C,2H], Ileδ1[13CH3],Leu,Val[
13CH3]}
AGR241–175 was prepared using a modified protocol to that
described by Tugarinov et al.42 A 5-mL culture of LB
medium was inoculated with a freshly transformed colony
of BL21 Star (DE3) cells and grown at 37 °C to an OD600 of
0.7. The cells were centrifuged at 1200g at room
temperature, resuspended in 20 mL of unlabeled M9/
H2O medium to a starting OD600 of 0.1 and incubated to
OD600 of 0.6. The cells were again centrifuged at 1200g,
resuspended in 100 mL M9/D2O medium, prepared with
[2H,13C]glucose and 15NH4Cl to a starting OD600 of 0.1
and grown to an OD600 of 0.5. The culture was diluted to
200 mL with M9/D2O medium and grown to an OD600 of
0.5. The culture was diluted to 1 L using the same M9/D2O
medium and grown to an OD600 of 0.25, after which 2-keto-
3-d2-1,2,3,4-
13C-butyrate and 2-keto-3-methyl-13C-d1-
4-13C-butyrate were added to final concentrations of
70 mg/L and 120 mg/L, respectively. The culture was
incubated further for 1 h, and protein expression wasinduced with 1 mM IPTG for 7–8 h at 30 °C. The process
of cell growth took 30 h from start to completion.
Cells were harvested and sonicated in 20 mM Tris–HCl
(pH 7.5), 500 mM NaCl and 20 mM imidazole; the soluble
fraction was obtained by centrifugation at 27,000g for
45 min. The supernatant was applied to a charged HisTrap
FF 5-mL affinity column (GE Healthcare); washed with
20 mM Tris–HCl (pH 7.5), 500 mM NaCl, 20 mM imidaz-
ole and eluted in 20 mM Tris (pH 7.5), 500 mMNaCl with a
linear imidazole gradient from 20 mM to 500 mM. The
eluted protein was cleaved with recombinant tobacco etch
virus protease overnight at 4 °C and further purified by gel
filtration on a Superdex-75 column (GE Healthcare).
Protein concentrations were determined from the absor-
bance at 280 nm.
All wild-type AGR241–175 samples for NMR were
prepared in 20 mM 4-morpholineethanesulfonic acid
(pH 6.5), 100 mM NaCl, 2 mM DTT, 0.02% (w/v) NaN3
and 10% (v/v) D2O or 99.9% D2O, at a final protein
concentration of 1 mM. E60A AGR241–175 samples were
prepared in 20 mM phosphate buffer (pH 6.0), 150 mM
NaCl, 3 mM DTT, 0.02% (w/v) NaN3 and 10% (v/v) D2O or
99.9% D2O, at a final protein concentration of 0.3–1.2 mM.
Mixed-labeled samples of AGR241–175 were made by
mixing equal concentrations of labeled and unlabeled wild-
type AGR241–175 at room temperature for between 1 h and
120 h and with gentle heating up to 40 °C for between
2 min and 15 min. Mild denaturing conditions were also
used in which hexahistidine-tagged 13C/15N-labeled
AGR241–175 and untagged unlabeled AGR241–175 were
incubated in 2 M urea overnight. The mixture was then
thoroughly dialyzed into non-denaturing buffer over a
period of 48 h. Nickel-affinity chromatography was then
used to isolate hexahistidine-tagged protein and eluted
with an imidazole gradient. Two peaks from the elution
gradient were observed, one corresponding to mixed-
labeled AGR241–175 and one corresponding to purely
labeled wild-type AGR241–175.Sedimentation equilibrium
Purified AGR241–175 was buffer exchanged into 20 mM
sodium phosphate (pH 6.5) with 150 mM NaCl, on a
Superdex-75 10/300 (GE Healthcare) column. The eluted
fractions were pooled and used for the dilution series. The
final concentrations were 62 μM, 31 μM and 6 μM, which
were loaded into 6-well Epon-filled centerpieces with
quartz windows. The samples were centrifuged at
15,000 rpm, 22,000 rpm and 30,000 rpm for 15 h at
20 °C performing scans at 290 nm, 280 nm and 232 nm
for the three concentrations and analyzed using the Sedfit/
Sedphat suite of programs.43Size-exclusion chromatography MALLS
Proteins were chromatographed on Superdex-75
300 mm×10 mm gel-filtration columns (GE Healthcare
Life Sciences) equilibrated in 50 mM phosphate and
50 mM NaCl (pH 6.8) at 0.71 mL/min. Elution was
monitored by a Wyatt EOS 18-angle laser photometer
(Wyatt Technology, Santa Barbara, CA), an Optilab rEX
refractive index detector and a Jasco UV-2077 Plus UV/
Vis spectrophotometer (Jasco, Easton, MD); these were
940 Structure and Activity of AGR2coupled to a quasi elastic light-scattering detector for
simultaneous measurement of hydrodynamic radius.
Molar mass measurements were performed using both
Astra 5.3.2.16 software (Wyatt Technology) and the “three
detector method”. Values of mass and hydrodynamic
radius are expressed as mean±standard error.
NMR spectroscopy
All spectra were acquired at 298 K on Bruker Avance
III 600- and 800-MHz spectrometers. For AGR241–175,
sequence-specific backbone resonance assignment was
obtained using transverse relaxation optimized spectros-
copy-based multidimensional heteronuclear NMR exper-
iments [HNCA, HN(CO)CA, HNCACB, CBCA(CO)NH,
HNCO, HN(CA)CO]. Leucine, isoleucine and valine side-
chain methyl group assignments were obtained from a
3D (H)CCH3–TOCSY experiment with 22.8 ms mixing
time.22 For E60A AGR241–175, sequence-specific back-
bone resonance assignment was obtained using stan-
dard NMR experiments [HNCA, HN(CO)CA, HNCACB,
CBCA(CO)NH, HNCO, HN(CA)CO, HBHANH, HBHA
(CO)NH]. Side-chain assignment was obtained using a
3D HCCH–TOCSY experiment. NOEs were derived from
3D 15N- and 13C-edited NOESY–HSQC and 3D HMQC-
NOESY-HMQC experiments with 200 ms mixing times.
Paramagnetic surface mapping studies were carried out
in 0.5–12 mM gadolinium complexed with diethylenetria-
mine pentaacetic acid (Gd-DTPA) and 5–30 mM
TEMPO, as paramagnetic relaxation agents. One-bond
1H–15N RDCs were obtained from [1H,15N] in-phase/
antiphase HSQC spectra. Values of the axial and
rhombic components of the molecular alignment tensor
for RDCs were obtained using the program PALES.44
RDC measurements
For dimeric AGR241–175, RDCs were collected in two
separate media: Pf1 bacteriophage (21 mg/mL) (Asla
Biotech) and 5% (v/v) pentaethylene glycol monododecyl
ether:hexanol in a 0.96:1 ratio. Protein concentrations in
the range 0.3–0.6 mM were used in these experiments.
The final values of the axial and rhombic components in
the refinement stage were, respectively, −18.95 Hz and
0.40 Hz. For E60A AGR241–175, RDCs were collected in
Pf1 bacteriophage medium and the final values of the axial
and rhombic components in the refinement stage were,
respectively, 14.05 Hz and 0.46 Hz.
NMR assignments and structure calculations
All NMR spectra were processed with TopSpin (Bruker)
and analyzed using the CCPN Analysis Package.
AGR241–175 and E60A AGR241–175 structure calculations
were carried out using the CNS.45 The structures of
AGR241–175 monomer subunit and E60A AGR241–175
monomer were carried out using the CNS program with
the IUPAC PARALLHDGv5.3 and TOPALLHDGv5.3
parameter sets. Backbone torsion angles were derived
from analysis of Cα, Cβ and C′ chemical shifts using the
TALOS+ program.46 The final set of calculated structures
was obtained from water-refinement calculations in
XPLOR-NIH.Dimer modeling
An RDC-assisted modeling method, suitable for the
structure determination of symmetrical dimers,23 was
used to orientate the monomeric subunits to obtain the
dimeric structure. The method relies on the fact that an
aligned protein has one of the principle axes of the
alignment tensor orientated in parallel with the symmetry
axis of the multimer. Hence, when the alignment tensors
of a protein in two or more different alignment media
are measured, the common alignment tensor is indica-
tive of the symmetry axis. We measured the RDCs of
AGR241–175 in two media, Pf1 bacteriophage (21 mg/
mL) (Asla Biotech) and 5% (v/v) pentaethylene glycol
monododecyl ether:hexanol. The REDCAT47 program
and the monomeric structure of AGR241–175 were used
to determine the alignment tensors in each medium.
Directions of the axes were plotted on a Sauson-
Flamsteed plot; the overlap of the PEG Sxx and
bacteriophage Syy alignment tensor axes indicated the
C2 symmetry axis of AGR241–175. Homodimer models in
agreement with this symmetry restraint were then
constructed using a grid-search algorithm, and these
models were evaluated based on the quality of the
interface between the subunits and the agreement with
the experimental data.
The VMD software package48 was used to generate
models of the homodimer. The lowest-energy structure
of the ensemble of calculated monomeric subunit
AGR241–175 structure was selected and rotated 180°
about the derived symmetry axis to generate the
orientation of the second subunit of the AGR241–175
homodimer. The grid search was performed using 230
steps in the x- and z-axes (1 step equivalent to 1 Å),
generating a total of 3002 dimeric models with different
x and z grid points. Generated models were rejected if
intermolecular backbone atoms were b4 Å or if the
closest intermolecular atomic distance was N2 Å, in
accordance with Ref. 23. Relaxation of the side chains
at the interface was performed with 500 ps molecular
dynamics simulation and 100 steps of energy minimi-
zation using the NAMD program49 and the CHARMM22
force field software. The calculated models were then
evaluated according to the correlation between mea-
sured and simulated RDC values using PALES and a
residue-pairing score for each model.50 Rigid-body
minimization was performed on the 20 best dimer
structures selected from the residue-pairing and RDC
correlation scores; 75.4% of the non-proline and non-
glycine residues are in the most favored regions of the
Ramachandran plot, 22.2% are in the additionally
allowed regions, 0.8% are in the generously allowed
regions and 1.6% are in the disallowed regions.
Biochemical analyses
Assay of free sulfhydryl groups was carried out using the
Ellman's assay, which is a colorimetric assay based on the
reaction between free thiol groups and DTNB.51 AGR2
(3.5 μM) and DTNB (4 mg/mL) in 0.1 M phosphate buffer
(pH 8.0) (total volume of 2.2 mL) were incubated for 5 min,
and the absorbance was measured at 412 nm. Bovine
RNase A and C81S AGR241–175 were used as negative
controls in these assays.
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Cell adhesion assays were performed as described by
Liu et al.6 24-well tissue culture plates with 1 nmol, or a
specified concentration of AGR2 protein, by air drying at
37 °C. Before use, coated wells were washed once with
phosphate-buffered saline and left to air dry at room
temperature. Cells were grown to 60–70% confluence,
trypsinized and counted using a Coulter counter (Beck-
man Coulter). The cells were then resuspended to 2×105
cells/mL, recounted and 1 mL of cell suspension added
to each well. Following a 60-min incubation at 37 °C,
cells were washed three times with phosphate-buffered
saline, 5×10− 4% (w/v) trypsin was added and the
number of released cells was determined. Adhesion
efficiency was calculated as the percentage of the total
number of cells added to the well that had adhered during
60 min. Error bars represent the standard errors of the
means from three independent experiments carried out
with duplicate wells.
Accession numbers
Accession codes are as follows: wild-type AGR241–175,
PDB ID: 2LNS; E60A AGR241–175, PDB ID: 2LNT; wild-
type AGR241–175 and E60A AGR241–175 chemical shifts,
BioMagResBank codes 18178 and 18179, respectively.Acknowledgements
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